I agree that this site is using cookies. You can find further informations here.
X
Mok, Tony
459  results:
Search for persons X
?
1

A pragmatic guide for management of adverse events associat..:

Liu, Geoffrey ; Mazieres, Julien ; Stratmann, Jan...
Lung Cancer.  191 (2024)  - p. 107535 , 2024
Link: https://doi.org/10.1016/..
 
?
2

D3S-001, a KRAS G12C inhibitor with rapid target engagement..:

Zhang, Jing ; Lim, Sun Min ; Yu, Mi Ra...
Cancer Discovery.  , 2024
Link: https://doi.org/10.1158/..
 
?
3

NTRK gene fusion testing and management in lung cancer:

Repetto, Matteo ; Chiara Garassino, Marina ; Loong, Herbert H....
Cancer Treatment Reviews.  127 (2024)  - p. 102733 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Face to face among different chemo-immunotherapy combinatio..:

Gridelli, Cesare ; Peters, Solange ; Mok, Tony...
Lung Cancer.  187 (2024)  - p. 107441 , 2024
Link: https://doi.org/10.1016/..
 
?
5

Entrectinib in ROS1-positive advanced non-small cell lung c..:

Peters, Solange ; Gadgeel, Shirish M. ; Mok, Tony...
Nature Medicine.  , 2024
Link: https://doi.org/10.1038/..
 
?
6

HERTHENA-Lung02: phase III study of patritumab deruxtecan i..:

Mok, Tony ; Jänne, Pasi A ; Nishio, Makoto...
Future Oncology.  20 (2023)  15 - p. 969-980 , 2023
Link: https://doi.org/10.2217/..
 
?
7

High-dose alectinib for RET fusion-positive non-small cell ..:

Dziadziuszko, Rafal ; Peled, Nir ; Mok, Tony...
Współczesna Onkologia.  27 (2023)  4 - p. 217-223 , 2023
Link: https://doi.org/10.5114/..
 
?
8

Asian Subgroup Analysis of the Randomized Phase 3 CROWN Stu..:

Zhou, Qing ; Soo, Ross A. ; Chang, Gee-Chen...
JTO Clinical and Research Reports.  4 (2023)  5 - p. 100499 , 2023
Link: https://doi.org/10.1016/..
 
?
9

NEPTUNE: Phase 3 Study of First-Line Durvalumab Plus Tremel..:

de Castro Jr., Gilberto ; Rizvi, Naiyer A. ; Schmid, Peter...
Journal of Thoracic Oncology.  18 (2023)  1 - p. 106-119 , 2023
Link: https://doi.org/10.1016/..
 
?
10

Patient-reported outcomes with durvalumab, with or without ..:

Garon, Edward B. ; Cho, Byoung Chul ; Luft, Alexander...
Lung Cancer.  186 (2023)  - p. 107422 , 2023
Link: https://doi.org/10.1016/..
 
?
11

NEPTUNE China cohort: First-line durvalumab plus tremelimum..:

Cheng, Ying ; Zhou, Qing ; Han, Baohui...
Lung Cancer.  178 (2023)  - p. 87-95 , 2023
Link: https://doi.org/10.1016/..
 
?
12

Analysis of acquired resistance mechanisms to osimertinib i..:

Chmielecki, Juliann ; Mok, Tony ; Wu, Yi-Long...
Nature Communications.  14 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
13

Expert Consensus Recommendations on Biomarker Testing in Me..:

Mitsudomi, Tetsuya ; Tan, Daniel ; Yang, James Chih-Hsin...
Journal of Thoracic Oncology.  18 (2023)  4 - p. 436-446 , 2023
Link: https://doi.org/10.1016/..
 
?
14

Treatment strategies and outcomes for patients with EGFR-mu..:

Johnson, Melissa ; Garassino, Marina Chiara ; Mok, Tony.
Lung Cancer.  170 (2022)  - p. 41-51 , 2022
Link: https://doi.org/10.1016/..
 
?
15

In Response to Outcomes by ALK Status (Immunohistochemistry..:

Mok, Tony
Journal of Thoracic Oncology.  17 (2022)  6 - p. e62-e63 , 2022
Link: https://doi.org/10.1016/..
 
1-15